Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

(2011) G Procopio et al.   BRITISH JOURNAL OF CANCER

Sunitinib and other targeted therapies for renal cell carcinoma

(2011) T Powles et al.   BRITISH JOURNAL OF CANCER

Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies

(2011) M E Gore et al.   BRITISH JOURNAL OF CANCER

Serum cell-free DNA in renal cell carcinoma

(2011) Michela de Martino et al.   CANCER

The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancer

(2010) Martin Heubner et al.   GYNECOLOGIC ONCOLOGY

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas

(2010) Bernard Paule et al.   PLoS One

Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage

(2008) R. H. Thompson et al.   CANCER RESEARCH

Serum Carbonic Anhydrase 9 Level is Associated With Postoperative Recurrence of Conventional Renal Cell Cancer

(2008) Guorong Li et al.   JOURNAL OF UROLOGY

Molecular Biology of Renal Cortical Tumors

(2008) Tobias Klatte et al.   UROLOGIC CLINICS OF NORTH AMERICA

Heat Shock Proteins 27, 60, 70, 90α, and 20S Proteasome in On-Pump Versus Off-Pump Coronary Artery Bypass Graft Patients

(2007) Tamas Szerafin et al.   ANNALS OF THORACIC SURGERY